切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2021, Vol. 08 ›› Issue (01) : 10 -13. doi: 10.3877/cma.j.issn.2095-8757.2021.01.003

所属专题: 文献

帕金森病

红景天苷对MPTP诱导帕金森病动物模型保护作用的研究
蔡苗1, 毕倩倩2, 魏博2, 毛根祥3, 刘小利1,()   
  1. 1. 310012 杭州,浙江医院神经内科
    2. 310029 杭州,浙江大学转化医学研究院
    3. 310030 杭州,浙江省老年医学研究所
  • 收稿日期:2020-07-15 出版日期:2021-02-28
  • 通信作者: 刘小利
  • 基金资助:
    国家自然科学基金面上项目(81771520)

Protective effect of salidroside on MPTP induced Parkinson's disease animal model

Miao Cai1, Qianqian Bi2, Bo Wei2, Genxiang Mao3, Xiaoli Liu1,()   

  1. 1. Department of Neurology, Zhejiang Hospital, Hangzhou 310013, China
    2. Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China
    3. Zhejiang Institute of Geriatrics, Hangzhou 310030, China
  • Received:2020-07-15 Published:2021-02-28
  • Corresponding author: Xiaoli Liu
引用本文:

蔡苗, 毕倩倩, 魏博, 毛根祥, 刘小利. 红景天苷对MPTP诱导帕金森病动物模型保护作用的研究[J]. 中华老年病研究电子杂志, 2021, 08(01): 10-13.

Miao Cai, Qianqian Bi, Bo Wei, Genxiang Mao, Xiaoli Liu. Protective effect of salidroside on MPTP induced Parkinson's disease animal model[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2021, 08(01): 10-13.

目的

探讨红景天苷对MPTP诱导的帕金森病小鼠模型神经元及自主神经功能的保护作用。

方法

将成年雄性C57/6J小鼠随机分为对照组(正常小鼠)、不用药的PD模型组(单纯模型组)、红景天苷治疗的PD模型组(红景天苷干预组,在MPTP给药前2周开始喂食溶解在饮用水中的红景天苷,40 mg·kg-1·d-1),每组6~8只。采用MPTP(10 mg/kg)腹腔注射建模,每天给药1次,连续给药4 d,在最后一针注射后的第7天处死小鼠。处死小鼠前,于麻醉状态下给予升压药和降压药,记录其血压及心率情况。处死小鼠后取待检脑组织,利用免疫组化法计数3组小鼠中脑黑质(substantia nigra pars compacta, SNpC)区、脑干孤束核(nucleus tractus solitaril, NTS)区和脑干延髓腹外侧(rostral ventrolateral medullary, RVLM)区的多巴胺神经元并比较分析。多组间的比较采用方差分析,进一步两两比较采用LSD-t检验。

结果

3组小鼠仅SNpC区神经元计数的差异有统计学意义(F=81.920,P<0.01),其中红景天苷干预组的神经元计数明显多于单纯模型组(P<0.05);3组小鼠RVLM区及NTS区神经元计数的差异均无统计学意义(F=7.970、11.660,均P>0.05)。3组小鼠心率变异性指标(交感神经活性、副交感神经活性以及两者比值)的差异均无统计学意义(F=0.97、1.57、1.05,均P>0.05)。3组小鼠麻醉状态下急性颈动脉插管压力反射斜率的差异均无统计学意义(F=1.500、1.940,均P>0.05)。

结论

红景天苷对于MPTP导致的SNpC纹状体多巴胺神经元的死亡具有保护作用,可以明显抑制PD的病理进程,但对自主神经功能无保护作用。

Objective

To investigate the protective effect of salidroside on neurons and autonomic nervous function in MPTP induced Parkinson's disease mouse model.

Methods

19 adult male C57 / 6J mice were randomly divided into control group (normal mice), PD model group without medication (PD group), and PD model group treated with salidroside (salidroside intervention group, salidroside dissolved in drinking water, 40 mg·kg-1·d-1, 2 weeks before MPTP administration), with 6-8 mice in each group. MPTP (10 mg/kg) was injected intraperitoneally once a day for 4 days. The mice were killed on the 7th day after the last injection. Before the mice were killed, the pressor and antihypertensive drugs were given under anesthesia, and the blood pressure and heart rate were recorded. After the mice were killed, dopaminergic neurons in substantia nigra pars compacta (SNPC), nucleus tractus solitaril (NTS) and rostral ventrolateral medullary (RVLM) were counted and analyzed by immunohistochemistry. Analysis of variance was used for comparison among groups, and LSD-t test was used for further pairwise comparison.

Results

There was significant difference in the number of neurons in SNPC area among the three groups (F=81.920, P < 0.01), and the number of neurons in salidroside intervention group was significantly higher than that in model group (P < 0.05). There was no significant difference in the number of neurons in RVLM and NTS among the three groups (F=7.970, 11.660, P > 0.05). There was no significant difference in sympathetic activity, parasympathetic activity and the ratio of the two among the three groups (F=0.97, 1.57, 1.05, P > 0.05). There was no significant difference in the slope of baroreflex among the three groups (F=1.500, 1.940, P > 0.05).

Conclusion

Salidroside has protective effects on the midbrain nigrostriatal dopaminergic neurons caused by MPTP, which can significantly inhibit the pathological process of PD. However, it has no protective effects on autonomic function.

表1 3组小鼠SNpC、RVLM、NTS脑区神经元计数的比较(个,±s
图1 3组小鼠交感神经活性的比较
图2 3组小鼠副交感神经活性的比较
图3 3组小鼠交感与副交感神经活性比值比较
图4 给予苯去甲肾上腺素后3组小鼠的压力反射斜率图
图5 给予硝普钠后3组小鼠的压力反射斜率图
[1]
Giguere N, Burke Nanni S, Trudeau LE. On cell loss and selective vulnerability of neuronal populations in Parkinson's disease[J]. Front Neurol, 2018, 9:455.
[2]
Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease[J]. Nat Rev Neurol, 2017, 13(4):217-231.
[3]
Schrag A, Anastasiou Z, Ambler G, et al. Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations[J]. Mov Disord, 2019, 34(4):480-486.
[4]
Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models[J]. Clin Auton Res, 2019, 29(4):397-414.
[5]
Barnum CJ, Tansey MG. Modeling neuroinflammatory pathogenesis of Parkinson's disease[J]. Prog Brain Res, 2010, 184:113-132.
[6]
Li HB, Ge YK, Zheng XX, et al. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase[J]. Eur J Pharmacol, 2008, 588(1-2):165-169.
[7]
Wang H, Ding Y, Zhou J, et al. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3[J]. Phytomedicine, 2009, 16(2-3):146-155.
[8]
Hu X, Lin S, Yu D, et al. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines[J]. Cell Biol Toxicol, 2010, 26(6):499-507.
[9]
Kuroiwa H, Yokoyama H, Kimoto H, et al. Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease[J]. Metabolic Brain Disease, 2010, 25(2):177-183.
[10]
Ferreira SA , Marina RR. Microglia response during Parkinson's disease: Alpha-synuclein intervention[J]. Front Cell Neurosci, 2018, 12:247.
[11]
Zhou F, Ju J, Fang Y, et al. Salidroside protected against MPP+-induced Parkinson's disease in PC12 cells by inhibiting inflammation, oxidative stress and cell apoptosis[J]. Biotechnol Appl Biochem, 2019, 66(2):247-253.
[12]
Wu D, Han X, Wen X, et al. Salidroside protection against oxidative stress injury through the wnt/β-catenin signaling pathway in rats with Parkinson's disease[J]. Cell Physiol Biochem, 2018, 46(5):1793-1806.
[13]
Wang S, He H, Chen L, et al. Protective effects of salidroside in the MPTP/MPP+-induced model of Parkinson's disease through ROS-NO-Related mitochondrion pathway[J]. Molecul Neurobiol, 2015, 51(2):718-728.
[14]
Li T, Zhang W, Kang X, et al. Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP+-induced model of Parkinson's disease[J]. J Neurochem, 2020, 153(2):276-289.
[15]
Braak H, Tredici KD, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease[J]. Neurobiol Aging, 2003, 24(2):197-211.
[16]
Langston JW, Forno LS, Tetrud JW, et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure[J]. Ann Neurol, 1999, 46(4):598-605.
[1] 李元子, 殷露, 何文, 肖杨, 周永进, 王雨萌, 杨静, 黄文燕, 张惠琴, 马惠姿, 杜丽娟. 动态超声弹性成像技术评估帕金森病肌强直程度的临床研究[J]. 中华医学超声杂志(电子版), 2021, 18(07): 696-700.
[2] 王帅, 赵丽霞, 王涛, 杨熊飞. 腹腔镜和开腹直肠后补片悬吊固定术治疗男性直肠脱垂的临床疗效对比[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 197-200.
[3] 李甫根, 罗文君, 钱川, 孙萌, 许政文. 以盆腔自主神经和固有筋膜为解剖标志的保留盆腔自主神经TME术对比研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 676-679.
[4] 王雄飞, 邵建平, 赵磊, 刘春庆, 刘正. 腹腔镜下PANP+TME与TME对男性直肠癌术后排尿、性功能的保护效果研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(01): 22-26.
[5] 卫洪波. 腹腔镜保留Denonvilliers 筋膜全直肠系膜切除术[J]. 中华普外科手术学杂志(电子版), 2022, 16(01): 18-18.
[6] 姬丽娅, 姬昂, 狄政莉, 熊婧, 刘志勤, 薛秀云, 费晓炜, 豆雅楠, 王利. 叶酸通过NLRP3/ASC/Caspase-1信号通路对HT22细胞拟帕金森损伤作用的研究[J]. 中华神经创伤外科电子杂志, 2022, 08(04): 196-203.
[7] 金刚, 李英真, 施维, 李博. 帕金森病在病理生理学中的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 315-319.
[8] 郑丽华, 钱一菁, 黄崇甄, 周春娜. 山茱萸环烯醚萜苷改善6-OHDA诱导帕金森病细胞模型的损伤[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(06): 324-331.
[9] 陈普建, 张璟, 陈芬, 陈怡伟, 余蓓蓓, 周春英. 双侧丘脑底核交叉电脉冲脑深部电刺激对帕金森病步态障碍的疗效观察[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(05): 298-301.
[10] 李玺琳, 章邱东. 帕金森病患者胃肠功能障碍特点及其风险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 145-149.
[11] 耿磊, 张照婷, 许磊, 黄海, 孙毅, 杨伏猛, 徐凯, 胡春峰. 帕金森病前驱期基底神经节环路磁共振弥散张量成像的应用研究[J]. 中华临床医师杂志(电子版), 2023, 17(9): 995-1003.
[12] 杨团峰, 孟雪, 王艳香, 卢葭, 孔德生, 赵元立, 刘献增. 男性帕金森病患者球海绵体肌反射初步研究[J]. 中华临床医师杂志(电子版), 2023, 17(01): 28-32.
[13] 谢艾伦, 郑冬燕, 蔡紫薇, 卢仁建, 彭永明, 张贺, 陈家隆. 鱼藤酮通过降低线粒体钙离子单向转运体蛋白表达促进多巴胺能神经元铁死亡[J]. 中华临床实验室管理电子杂志, 2023, 11(02): 71-78.
[14] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15] 韩远远, 于紫涵, 杨玲, 程弘禹, 宋春杰. C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值对老年帕金森病的诊断价值[J]. 中华老年病研究电子杂志, 2023, 10(01): 14-19.
阅读次数
全文


摘要